Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) S.A.E. reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported sales was EGP 368.44 million compared to EGP 266.93 million a year ago. Net income was EGP 52.41 million compared to EGP 31.6 million a year ago. Basic earnings per share from continuing operations was EGP 0.0525 compared to EGP 0.0316 a year ago.
For the six months, sales was EGP 711.5 million compared to EGP 537.77 million a year ago. Net income was EGP 124.2 million compared to EGP 61.77 million a year ago. Basic earnings per share from continuing operations was EGP 0.1245 compared to EGP 0.0618 a year ago.